Cargando…

Structural Mechanism of the Oxygenase JMJD6 Recognition by the Extraterminal (ET) Domain of BRD4

Jumonji domain-containing protein 6 (JMJD6) is a member of the Jumonji C family of Fe(II) and 2-oxoglutarate (2OG) dependent oxygenases. It possesses unique bi-functional oxygenase activities, acting as both an arginine demethylase and a lysyl-hydroxylase. JMJD6 has been reported to be over-expresse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Konuma, Tsuyoshi, Yu, Di, Zhao, Chengcheng, Ju, Ying, Sharma, Rajal, Ren, Chunyan, Zhang, Qiang, Zhou, Ming-Ming, Zeng, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701133/ https://www.ncbi.nlm.nih.gov/pubmed/29176719 http://dx.doi.org/10.1038/s41598-017-16588-8

Ejemplares similares

Epigenetic readers and lung cancer: the rs2427964C>T variant of the bromodomain and extraterminal domain gene BRD3 is associated with poorer survival outcome in NSCLC
por: Lee, Jang Hyuck, et al.
Publicado: (2021)

Bromo‐ and extraterminal domain protein inhibition improves immunotherapy efficacy in hepatocellular carcinoma
por: Liu, Chen, et al.
Publicado: (2020)

The Jumonji-C oxygenase JMJD7 catalyzes (3S)-lysyl hydroxylation of TRAFAC GTPases
por: Markolovic, Suzana, et al.
Publicado: (2018)

Specific Recognition of Arginine Methylated Histone Tails by JMJD5 and JMJD7
por: Liu, Haolin, et al.
Publicado: (2018)

Double-bromo and extraterminal (BET) domain proteins regulate dendrite morphology and mechanosensory function
por: Bagley, Joshua A., et al.
Publicado: (2014)

Bromodomain and extraterminal domain inhibitor enhances the antitumor effect of imatinib in gastrointestinal stromal tumours
por: Mu, Jianfeng, et al.
Publicado: (2020)

Biochemical and structural investigations clarify the substrate selectivity of the 2-oxoglutarate oxygenase JMJD6
por: Islam, Md. Saiful, et al.
Publicado: (2019)

Native Mass Spectrometry of BRD4 Bromodomains Linked to a Long Disordered Region
por: Azegami, Nanako, et al.
Publicado: (2022)

Bromodomain and extraterminal (BET) proteins: biological functions, diseases, and targeted therapy
por: Wang, Zhi-Qiang, et al.
Publicado: (2023)

The bromodomain and extraterminal domain inhibitor bromosporine synergistically reactivates latent HIV-1 in latently infected cells
por: Pan, Hanyu, et al.
Publicado: (2017)

Targeting basal-like breast tumors with bromodomain and extraterminal domain (BET) and polo-like kinase inhibitors
por: Nieto-Jiménez, Cristina, et al.
Publicado: (2017)

Bromodomain and Extraterminal Domain (BET) Protein Inhibition Hinders Glioblastoma Progression by Inducing Autophagy-Dependent Differentiation
por: Colardo, Mayra, et al.
Publicado: (2023)

Regulation of Cell Plasticity by Bromodomain and Extraterminal Domain (BET) Proteins: A New Perspective in Glioblastoma Therapy
por: Gargano, Deborah, et al.
Publicado: (2023)

Structural analysis of the 2-oxoglutarate binding site of the circadian rhythm linked oxygenase JMJD5
por: Islam, Md. Saiful, et al.
Publicado: (2022)

Bromodomain and Extraterminal Proteins as Novel Epigenetic Targets for Renal Diseases
por: Morgado-Pascual, Jose Luis, et al.
Publicado: (2019)

Validation of Bromodomain and Extraterminal proteins as therapeutic targets in neurofibromatosis type 2
por: Doherty, Joanne, et al.
Publicado: (2022)

JMJD8 is a novel endoplasmic reticulum protein with a JmjC domain
por: Yeo, Kok Siong, et al.
Publicado: (2017)

Inhibition of Bromodomain and Extraterminal Domain (BET) Proteins by JQ1 Unravels a Novel Epigenetic Modulation to Control Lipid Homeostasis
por: Tonini, Claudia, et al.
Publicado: (2020)

Combination bromo- and extraterminal domain and poly (ADP-ribose) polymerase inhibition synergistically enhances DNA damage and inhibits neuroblastoma tumorigenesis
por: Jacobson, Jillian C., et al.
Publicado: (2022)

Histone demethylase JMJD2C: epigenetic regulators in tumors
por: Zhang, Chengcheng, et al.
Publicado: (2017)

Potent bromodomain and extraterminal domain inhibitor JAB-8263 suppresses MYC expression and exerts anti-tumor activity in colorectal cancer models
por: Liu, Xin-Mo, et al.
Publicado: (2023)

Crystal structure of higher plant heme oxygenase-1 and its mechanism of interaction with ferredoxin
por: Tohda, Rei, et al.
Publicado: (2020)

Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma
por: Chen, Ye, et al.
Publicado: (2019)

Bromodomain and Extraterminal (BET) Protein Inhibition Restores Redox Balance and Inhibits Myofibroblast Activation
por: Stock, Carmel J. W., et al.
Publicado: (2019)

Inhibition of bromodomain extraterminal histone readers alleviates skin fibrosis in experimental models of scleroderma
por: Vichaikul, Sirapa, et al.
Publicado: (2022)

Widespread hydroxylation of unstructured lysine-rich protein domains by JMJD6
por: Cockman, Matthew E., et al.
Publicado: (2022)

The Novel Protease Activities of JMJD5–JMJD6–JMJD7 and Arginine Methylation Activities of Arginine Methyltransferases Are Likely Coupled
por: Liu, Haolin, et al.
Publicado: (2022)

Bromodomain and extraterminal inhibitors block the Epstein-Barr virus lytic cycle at two distinct steps
por: Keck, Kristin M., et al.
Publicado: (2017)

JMJD6–BRD4 complex stimulates lncRNA HOTAIR transcription by binding to the promoter region of HOTAIR and induces radioresistance in liver cancer stem cells
por: Pei, Ruifeng, et al.
Publicado: (2023)

The Role of Bromodomain and Extraterminal (BET) Proteins in Controlling the Phagocytic Activity of Microglia In Vitro: Relevance to Alzheimer’s Disease
por: Matuszewska, Marta, et al.
Publicado: (2022)

Molecular Recognition of H3/H4 Histone Tails by the Tudor Domains of JMJD2A: A Comparative Molecular Dynamics Simulations Study
por: Ozboyaci, Musa, et al.
Publicado: (2011)

BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis
por: Roberts, Thomas C., et al.
Publicado: (2017)

JMJD6 and U2AF65 co-regulate alternative splicing in both JMJD6 enzymatic activity dependent and independent manner
por: Yi, Jia, et al.
Publicado: (2017)

Suppression of YAP/TAZ-Notch1-NICD axis by bromodomain and extraterminal protein inhibition impairs liver regeneration
por: Liu, Chen, et al.
Publicado: (2019)

Promotion of adipogenesis by JMJD6 requires the AT hook-like domain and is independent of its catalytic function
por: Reyes-Gutierrez, Pablo, et al.
Publicado: (2019)

Role of JMJD6 in Breast Tumourigenesis
por: Poulard, Coralie, et al.
Publicado: (2015)

JMJD3 in the regulation of human diseases
por: Zhang, Xiangxian, et al.
Publicado: (2019)

The Functions of the Demethylase JMJD3 in Cancer
por: Sanchez, Anna, et al.
Publicado: (2021)

JMJD family proteins in cancer and inflammation
por: Manni, Wang, et al.
Publicado: (2022)

Impact of JMJD6 on intrahepatic cholangiocarcinoma
por: Kosai-Fujimoto, Yukiko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hg0ar6a0dchia6usa3hvco2qm7